Follow
Jeroen Luyten
Jeroen Luyten
Leuven Unit for Health Technology Assessment Research, KU Leuven
Verified email at kuleuven.be - Homepage
Title
Cited by
Cited by
Year
Estimated research and development investment needed to bring a new medicine to market, 2009-2018
OJ Wouters, M McKee, J Luyten
Jama 323 (9), 844-853, 2020
13372020
Assessing vaccine hesitancy in the UK population using a generalized vaccine hesitancy survey instrument
J Luyten, L Bruyneel, AJ Van Hoek
Vaccine 37 (18), 2494-2501, 2019
1962019
The social value of vaccination programs: beyond cost-effectiveness
J Luyten, P Beutels
Health Affairs 35 (2), 212-218, 2016
1002016
Willingness to get vaccinated against Covid-19 and attitudes toward vaccination in general
R Kessels, J Luyten, S Tubeuf
Vaccine 39 (33), 4716-4722, 2021
872021
Public preferences for prioritizing preventive and curative health care interventions: a discrete choice experiment
J Luyten, R Kessels, P Goos, P Beutels
Value in Health 18 (2), 224-233, 2015
812015
Costing infectious disease outbreaks for economic evaluation: a review for hepatitis A
J Luyten, P Beutels
Pharmacoeconomics 27, 379-389, 2009
672009
Challenges and opportunities for occupational health and safety after the COVID-19 lockdowns
L Godderis, J Luyten
Occupational and environmental medicine 77 (8), 511-512, 2020
572020
Economic evaluation of mental health interventions: an introduction to cost-utility analysis
J Luyten, H Naci, M Knapp
BMJ Ment Health 19 (2), 49-53, 2016
482016
Rationing of a scarce life‐saving resource: Public preferences for prioritizing COVID‐19 vaccination
J Luyten, S Tubeuf, R Kessels
Health economics 31 (2), 342-362, 2022
45*2022
Productivity estimation in economic evaluations of occupational health and safety interventions: a systematic review
J Steel, L Godderis, J Luyten
Scandinavian journal of work, environment & health 44 (5), 458-474, 2018
402018
Economic evaluation of vaccines: Belgian reflections on the need for a broader perspective
L Annemans, P Beutels, DE Bloom, W De Backer, O Ethgen, J Luyten, ...
Value in Health 24 (1), 105-111, 2021
362021
Quantifying the public's view on social value judgments in vaccine decision-making: a discrete choice experiment
J Luyten, R Kessels, KE Atkins, M Jit, AJ Van Hoek
Social Science & Medicine 228, 181-193, 2019
352019
Kicking against the pricks: vaccine sceptics have a different social orientation
J Luyten, P Desmet, V Dorgali, N Hens, P Beutels
The European Journal of Public Health 24 (2), 310-314, 2014
332014
Vaccination policy and ethical challenges posed by herd immunity, suboptimal uptake and subgroup targeting
J Luyten, A Vandevelde, P Van Damme, P Beutels
Public health ethics 4 (3), 280-291, 2011
332011
The Sexual Ethics of HPV Vaccination for Boys
J Luyten, B Engelen, P Beutels
HEC Forum 26 (1), 1-16, 2013
272013
Belgium's response to the COVID-19 pandemic
J Luyten, E Schokkaert
Health Economics, Policy and Law 17 (1), 37-47, 2022
232022
Ethical considerations for movement mapping to identify disease transmission hotspots
BC de Jong, BM Gaye, J Luyten, B van Buitenen, E André, CJ Meehan, ...
Emerging infectious diseases 25 (7), 2019
232019
Public preferences over efficiency, equity and autonomy in vaccination policy: an empirical study
J Luyten, V Dorgali, N Hens, P Beutels
Social Science & Medicine 77, 84-89, 2013
232013
Imputing QALYs from Single Time Point Health State Descriptions on the EQ-5D and the SF-6D: A Comparison of Methods for Hepatitis A Patients
J Luyten, C Marais, N Hens, K De Schrijver, P Beutels
Value in Health, 2011
222011
Cost-effectiveness of hepatitis A vaccination for adults in Belgium
J Luyten, S Van de Sande, K De Schrijver, P Van Damme, P Beutels
Vaccine 30 (42), 6070-6080, 2012
212012
The system can't perform the operation now. Try again later.
Articles 1–20